Previous product
Back to products
Margenza (margetuximab-cmkb)
CHF2,720.25
Next product
Padcev (enfortumab vedotin-ejfv)
CHF5,350.80
Danyelza (naxitamab-gqgk)
CHF35,282.47
Danyelza (naxitamab-gqgk) is a medication used to treat children aged 1 year or older and adults with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow.
Category: Oncology
Reviews
There are no reviews yet.